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Introduction
Healthcare investment is critically important for the 
health and well-being of the population, and different 
health systems are developed to meet the needs and 
priorities of each country. What has become clear has 
been that despite major advances in medicine, science 
and technology, there are major issues related to 
access and equity as well as quality and patient safety 
in healthcare services. The issue of patient safety was 
highlighted by the reports of the Institute of Medicine, 
USA1,2 and this had received worldwide attention. 
It is also an irony that despite being in an age of 
major advances in medicine, science and technology, 
with the acceptance of evidence-based medicine, 
so much of medicine and healthcare delivered is of 
little or no proven value. This poses a major challenge 
on health policy, and on how this can be addressed in 
any health reform process that focuses on improving 
access, equity, efficiency and effectiveness in healthcare 
services. 
In addressing this issue, we will look at three examples 
of approaches taken to improve access, equity, quality 
and patient safety, supported by health research:
•	 Health	Systems	Research
•	 The	Global	Forum	for	Health	Research	efforts	in	
promoting research to improve the health of poor 
people
•	 Comparative	Effectiveness	Research	initiative	by	
the	Patient-Centred	Outcomes	Research	Institute,	
founded	under	the	auspices	of	the	Affordable	Care	
Act (2010)
The first two were initiatives of the World Health 
Organisation	 (WHO),	 while	 the	 third	 was	 by	 the	
government of the United States of America.
Health System Research
Health Research may be defined as the generation of 
knowledge to characterise and solve health problems.1 
The evolution of concepts and research approaches 
to support health development resulted in the concept 
of Health Systems Research (HSR) introduced in 
1982	 by	 the	 World	 Health	 Organisation	 (WHO),	
as an alternative means to view the health services. 
HSR has the objective of facilitating the selection and 
application of an appropriate structure of healthcare and 
technologies to prevailing need and conditions.3
The	WHO	in	1985	passed	a	resolution	for	countries	
to apply HSR more systematically and intensively to 
ensure appropriateness of health technology absorbed 
and applied in the healthcare system. The then Director 
General	of	Health,	Tan	Sri	Dr	Abdul	Khalid	Sahan,	
took up the initiative for Malaysia to apply HSR into 
our health system and numerous research projects were 
implemented to improve the delivery of health services 
by	 the	 Ministry	 of	 Health	 (MOH)	 Malaysia.3 These 
research projects were done by teams from the national, 
state, district and institutional levels, to solve problems 
at the national or local levels and had immediate 
applicability.	The	WHO	Collaborating	Centre	for	HSR	
was at the Institute of Public Health in Kuala Lumpur. 
In starting the National Quality Assurance Programmes 
(QAP) for the different services in the Ministry of 
Health, numerous HSR studies had to be done to 
develop standards and methodology for the QAP for the 
different	programmes	in	the	MOH.	There	are	numerous	
examples of research projects to solve problems, and 
develop operating policies.4
Generally	HSR	is	about	working	to	more	effectively	
and efficiently utilise available resources in delivery of 
health services. HSR deals with solving problems rather 
than curiosity, and has the interest of decision makers in 
driving the research.
Problems in health development tend to be very 
complex and need to be viewed from different 
perspectives.5 HSR is action oriented as research is done 
to improve the health system. The approach to HSR 
projects is always multi-disciplinary, as it reflected in 
Figure	1.5S 3
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Figure 1:	Health	System	Components	and	their	Relationship5
People’s Health
Health Research is important for our future. In 
1999, investment in health research and development 
by the public and private sectors globally, was about 
US$56 billion a year. About 90% of this was invested 
in research into health problems that concerned 10% 
of	the	world’s	population.	Only	10%	of	available	funds	
were available to research on improving the health of 
90% of the world’s population. This disparity had been 
referred to as the 10/90 Disequilibrium6,	by	the	Global	
Forum	for	Health	Research	of	WHO.
In	 1996,	 the	 committee	 of	 the	 Global	 Forum	 for	
Health Research identified four major challenges6:
•	 The	 huge	 and	 unnecessary	 burden	 of	 infectious	
diseases among the poor that can be addressed 
with existing cost-effective interventions (“the 
unfinished agenda”)
•	 The	 continually	 changing	 nature	 of	 microbial	
threats, such as HIV/AIDs, tuberculosis, and 
malaria
•	 The	epidemics	of	non-communicable	diseases	and	
injuries in low-and middle-income countries, such 
as heart diseases, neuro-psychiatric conditions, 
violence and road traffic accidents
•	 The	great	disparity	in	how	efficiently	and	equitably	
different health systems provide services
The	Global	Forum	had	adopted	five	strategies	to	help	
provide solutions to the health challenges6:
1.  Annual forum to address the 10/90 Disequilibrium
2.  Analytical work for Priority Setting in the 
following areas:
a.  Burden of disease and health determinants
b.	 Cost-effectiveness	 analyses	 and	 methods	 to	
assist resource allocation
c. Analyses of resource flows and monitoring 
progress in correcting 10/90 gap
d.  Analytical work on specific conditions in the 
forum priority area
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3.  Initiatives in key health research areas:
a.  Alliance for Health Policy and Systems 
Research 
b.	 Global	Tuberculosis	Research	Initiative
c.	 Initiative	 for	 Research	 on	 Cardiovascular	
Disease
d.  Initiative on Domestic Violence against women
e.  Initiative on Health and Service
f. Initiative on Prevention of Violence and 
injuries
g.  Public/Private Partnership against Malaria
4.	 Communication	 and	 information,	 through	 the	
publication of 10/90 Report on Health Research, 
maintenance of website, communication to 
international and national media, and publication 
of a series of technical papers called the Strategic 
Research Series.
5.  Evaluation and monitoring: measuring the progress 
in the correction of the 10/90 Disequilibrium
The context for priority setting in health
Despite the advances in global health, it has been 
recognised that inequalities in health have widened, 
the environment has deteriorated and obstacles remain 
in	the	quest	of	health	for	all.	The	WHO	in	1998	has	
identified the need for re-evaluation in the following 
areas7: 
•	 Determinants	of	health
•	 Health	patterns	in	the	future
•	 Intersectoral	action
•	 Partnerships	in	health
•	 Health	personnel
•	 Dynamic	and	proactive	role	for	WHO	
Priority setting in health research
Generally	 priority	 setting	 based	 on	 economic	
evaluations would emphasise health maximisation. This 
would be reflected in the objectives of most national 
health systems that emphasise efficiency and “value 
for money”. The importance of access and equity and 
measurement of the burden of disease are important 
issues with a research agenda.
Priority setting in health at the national level is 
exceedingly complex, involving many processes at the 
district, state and national, even global levels. At the 
country level, it has to be acceptable in terms of the 
political process. There is a reasonably structured process 
for this in Malaysia. In some countries like Sweden the 
democratic process is involved at a high level from the 
beginning.8
The priorities for health research at country level would 
be to support the priorities set for health development, 
and taking into account the disease burden of the country. 
In tracking country resource flows for health research 
and development, a comparative study on Malaysia, 
the Philippines and Thailand, showed that Malaysia 
was the most successful in aligning financial resources 
with health research priority areas. This was probably 
because the government was both the main source and 
main user of health research and development (R & D) 
funds. In the Philippines, diverse sources and users of 
health funds resulted in health R&D spread in diverse 
areas, not necessarily in line with health priorities.9
The	 Ad	 Hoc	 Committee	 on	 Health	 Research	 of	
WHO	had	proposed	a	methodology	for	priority	setting	
in health R&D, involving a 5-step process.6 It involved 
seeking answers to the following:
•	 How	large	is	the	problem?	(magnitude)
•	 Why	 does	 the	 burden	 of	 disease	 persists?	
(persistence)
•	 How	 adequate	 is	 the	 current	 knowledge	 base?	
(Knowledge base)
•	 Is	the	planned	research	likely	to	yield	interventions	
significantly	better	than	the	existing	ones?	(cost	
effectiveness)
•	 How	 much	 is	 spent	 already?	 (current	 resource	
flows)S 5
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Assessing the burden of the health problem to identify 
research	needs	is	an	important	part	of	this	process.	Figure	
2 shows the burden from a specific disease. It shows the 
population coverage and the efficacy and effectiveness 
of interventions. What is also shown are the research 
potential and the type of research that is required.6
Comparative Effectiveness Research
The	 Patient	 Protection	 and	 Affordable	 Care	 Act	
(2010) includes an “initiative to determine which 
therapies, care management, delivery models and even 
public health programmes accomplish the most good”.10 
Towards this objective the Act created the Patient-
Centred	 Outcomes	 Research	 Institute	 to	 promote	
and fund comparative effectiveness research and to 
ensure that the product of this research is relevant in 
the real-life setting and creates value.11	 Alan	 Garber	
had recommended that the comparative effectiveness 
assessment format should “compare interventions based 
on the clinical risks and benefits, economic consideration 
and the insights they might offer into medical care”.11 
There has also been a proposal to set up a high 
performing comparative effectiveness research system 
that builds on the power of high-speed computers to 
a new national system of clinical research databases.12 
This will involve drawing on the electronic health records 
of millions of patients, obtaining relevant information 
for effectiveness studies and putting it into the new 
national system of clinical research databases. This will 
enable more studies on comparative effectiveness to be 
done quickly.
Evidentiary Standards for Comparative Effectiveness 
Research
The use of comparative effectiveness research in 
policy decisions implies the need for evidentiary 
Figure 2: Analysing the burden of a health problem to identify research needs.6 Relative shares of the burden that can 
and cannot be averted with existing tools
 
 
 
 
x - population coverage with current mix of interventions
y - maximum achievable coverage with a mix of available cost-effective interventions
z - combined efficacy of a mix of all available 
(Source: reprinted from Report of the Ad Hoc Committee, 1996)
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standards to be known, and preferably consistent 
with other standards applied in similar situations. 
Comparative	effectiveness	research	will	include	systemic	
reviews, observational studies and random controlled 
trials.	Garrison	et.al. have proposed that in comparative 
effectiveness research, the focus should be on standards 
in methodology and best scientific practice for each 
type of comparative effectiveness research, and not on 
evidentiary standards for use of the research.13
Decision makers are faced with varying types of 
decision making, depending on the different policy issues 
to be addressed. They need to be able to rely on a range 
of high quality research to make informed decisions.13,14 
While	 the	 FDA	 needs	 to	 approve	 a	 new	 technology	
(drug, device, or procedure) for sale, a doctor needs to 
recommend a certain technology to use on patients, 
the funding agency decides on which intervention 
can be reimbursed. The evidentiary standards applied 
in decision making may vary.13 A balanced approach 
to the acceptance of evidentiary standards is needed 
to maximise the value of information arising from 
comparative effectiveness research, to enable timely 
decision making that benefits the stakeholders.
Conclusion
This paper provides a very brief overview of the broad 
scope and different components of health research. 
It also provides a sketch on the interrelationships 
between health research and policy making at different 
levels. It includes how health research helps in decision 
making at the operational levels at institutional or 
district levels. It can also include policy making, which 
includes the setting of priorities for health, the state, 
national or international levels. The examples cited 
are based on work by various experts in the World 
Health	 Organisation.	 In	 the	 USA,	 experts	 working	
on comparative effectiveness research have come up 
with innovative ideas and recommendations on how 
to make research results become available to decision 
makers in a timely manner to benefit the stakeholders. 
Comparative	 effectiveness	 research	 in	 promoting	 the	
emphasis on effectiveness on specific populations groups 
of various interventions, will help chart the approach 
towards personalised medicine. This will be among the 
ways in future that can improve patient outcomes and 
rationalise health care costs.15 
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